A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Status:
Recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants
with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of
PsA.